hematologic system
DESCRIPTION
HEMATOLOGIC SYSTEM. Ch. 14 Goodman. OVERVIEW. *The hematologic system involves the blood, blood vessels and the associated organs. *The study of hematology includes the diseases of the hematological system. - PowerPoint PPT PresentationTRANSCRIPT
HEMATOLOGIC SYSTEM
Ch. 14Goodman
*The hematologic system involves the blood, blood vessels and the associated organs.
*The study of hematology includes the diseases of the hematological system.
* This critical system is tightly integrated with the following systems: lymphatic, immune, circulatory, respiratory. It is also integrated with hormonal and metabolic functions.
***While there are primary diseases of the hematological system, the most common conditions are most often signs of other conditions
OVERVIEW
*2 components of blood:◦ Plasma◦ Formed elements
Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets)
COMPONENTS OF BLOOD
Edema (sign)Excessive fluid accumulation within the interstitial tissues or within body cavities
Infarction (sign)localized region of necrosis caused by reduction of arterial perfusion
Thrombus (sign)blood clot - solid mass within intact vessel or the heart
Embolus (sign)Thrombus on the move that gets lodged distant from its place of origin
SIGNS OF HEMATOLOGICALDISORDERS
Lymphedema (sign)Can be a sign of hematologic conditions - increased lymphatic load associated withdecreased plasma proteins
Bleeding / bruising (sign)A sign when it happens with minor trauma or if bleeding continues longer than normal
Shock (sign)Inadequate blood pressure to perfuse organs
MORE SIGNS….
Lymphedenopathy (sign)Abnormal enlargement of lymph nodes
Splenomegalyenlarged spleen (spleen removes old RBC’s and antibody-laden bacteria or cells)
AND STILL MORE…
Aging and the Hematopoietic System Decreased red marrow Decreased intestinal iron absorption Increased fragility of plasma membranes Increased fibrinogen and platelet
adhesiveness Earlier activation of coagulation system (ergo…) disturbed blood flow, propensity
for anemia (low RBCs) - if nothing else slower RBC recovery from a loss of blood
AGING/HEMATOPOIETIC SYSTEM
Blood Transfusions Reaction to blood and blood products 1. Febrile nonhemolytic reaction - most common (.5-1% of
transfusions), fever (at least 1 degree rise) but stable cells 2. Transfusion related acute lung injury - 1 in every 2000
transfusions; initially mild shortness of breath but can progress to appear clinically as acute respiratory distresssyndrome (widespread inflammation, low ventilatory volumes, poor oxygenation); with treatment can prevent / minimize permanent lung damage
3. Acute hemolytic transfusion - 1 in every 25,000 transfusions - severe response due toABO incompatibility; RBCs are destroyed (lysis) - mortality rate is high (17-60%)
BLOOD TRANSFUSION REACTIONS
4. Allergic reactions - 1-3% of all transfusions, most common with fresh frozen plasmaand platelet transfusions - allergic reaction
5. Anaphylaxis - 1 in 20,000 transfusions - acute onset of hypotension, laryngeal edema
6. Sepsis - very rare; due to bacterial contamination of blood products used in transfusion
Bloodless medicine - goal to reduce blood loss with procedures to avoid need of transfusions
BLOOD TRANSFUSION REACTIONS (CONTINUED):
Disorders of Iron Absorption Hereditary Hemochromatosis is an autosomal
recessive hereditary disorder characterizedby excessive iron absorption by small intestine
Uncoupling of absorption and needs - leads to iron deposition in cells, particularly theliver, pancreas and heart
Early signs include weakness, hepatomegaly, elevated liver enzymes; symptoms includemyalgias, joint pain, fatigue
DISORDERS of IRON ABSORPTION
Diagnosis -by blood work Treatment - therapeutic phlebotomy Prognosis -is good (from a mortality /
morbidity perspective) but the condition is not reversible - it is managed
Hereditary Hemochromatosis (continued)
Anemia 1. Definition reduction in oxygen carrying capacity of
blood due to reduced quantity or quality of RBCs HgB < 14 g/100 ml for men; 12 g/ 100 ml
for women
DISORDERS OF ERYTHROCYTES
2. Overview Not technically a disease - really a sign of other
underlying disorders - including but not limited to: ** dietary (folate, vitamin B12) **acute or chronic blood loss ** iron deficiency (diet or absorption) ** congenital defects (sickle cell anemia) **poison exposure ** disease of bone marrow **chronic inflammatory, infectious or neoplastic disease ** any disorder that upsets the balance between blood
loss through bleeding or destructionand production of RBCs
Anemia (continued)
3. Clinical manifestations Mild - minimal and vague symptoms of
fatigue Moderate to severe progression: weakness,
dyspnea on exertion, tachycardia, increasedangina in pre existing CAD, dementia
4. Treatment a. Underlying problem (cause) if possible b. Blood transfusions
Anemia (continued)
Disorders of Leukocytes A. Leukocytosis
** Definition & Etiology Increased number of leukocytes (WBCs) for a variety
of causes - including as a normal response stressors Common finding with infection - > 10,000
WBCs/mm^3**Clinical manifestations
Signs and symptoms are usually those of infectious conditions (localized or systemic) -fever, headache, shortness of breath
** TreatmentUnderlying problem
DISORDERS OF LEUKOCYTES
B. Leukopenia**Definition & Etiology
Decreased number of WBCs - < 5000 / ml caused by a variety of conditions:* HIV, hepatitis*alcohol* Nutritional deficiencies*connective tissue disorders (SLE)* bone marrow failure (i.e. following antineoplastic chemotherapy)**Clinical manifestations
Asymptomatic; increased risk of infection**Treatment
Underlying problem
Disorders of Leukocytes
**** Bone marrow transplantTreatment of choice for any hematologic neoplastic disease A. Leukemias Malignant neoplasm of blood forming cells that replaces normal bone
marrow with a malignant clone Acute vs. Chronic Myeloid vs. Lymphocytic Blastic vs. cytic Acute progresses quickly; chronic slowly Myeloid - bone marrow origin involving hematopoeitic stem cells Lympho - involving lymphoid or lymphatic system Blastic - large, immature (functionless) cells cytic - immature, smaller cells Immunologically can also classify as T-cell / natural killer cell and B-cell
leukemias
NEOPLASTIC DISEASES OF THE BLOOD AND LYMPH SYSTEMS
Three main clinical consequences: 1. Anemia 2. Infection 3. Bleeding tendencies Acute myelogenous leukemia - AML - most common
leukemia in adults Acute lymphoblastic leukemia - ALL – diagnosed most
commonly in children Chronic myeloid leukemia - CML – occurs most often
in adults Chronic lymphocytic leukemia - CLL – a common type
of adult leukemia
Leukemia (continued)
Malignant Lymphomas Cancers of lymphatic system Two groups - Hodgkin’s lymphoma and Non-
Hodgkin’s Lymphoma (HL and NHL) - although the distinction has become less clear More useful to categorize based on cell behavior
- indolent vs. aggressive HL is distinguished from others by presence of a
cell known as the Reed-Sternberg cell in the lymph nodes
MALIGNANT LYMPHOMAS
HL - adults and children; B-cell malignancy; Clinical manifestations are variable, Box
14-6, Ann Arbor Staging Classification for HD (Hodgkin’s Disease) - progresses by increased involvement of lymph nodes and other lymph organs; Stage IV includes involvement of extralymphatic
organs (liver, lung, skin)
Hodgkin’s Lymphoma
NHL - large group (~30 types) of lymphoid malignancies that present as solid tumors
arising from lymphatic cells - 5th most common type of cancer in the US with an incidence of ~67,000 / year; clinical manifestations are variable
Non-Hodgkin’s Lymphoma
Multiple Myeloma MM - primary malignant neoplasm of plasma
cells arising in bone marrow Progression causes damage to kidney,
recurrent infections, often affects the nervoussystem
Increased incidence (doubled in past 2 decades) (~16,000 new cases / year) - thought in part to increase in population > 85 years old
MULTIPLE MYELOMA
Myeloproliferative Disorders Originate from a hematopoietic stem cell
that has transformed to allow the cell to matureand function with uncontrolled function - common characteristics include:
1. hypercellular bone marrow 2. tendency to thrombosis and hemorrhage 3. increased risk of evolving into acute
leukemia
MYELOPROLIFERATIVE DISORDERS
Polycythemia vera - increased production of RBCs
Essential thrombocythemia - most common - increased platelet count
Types of Myeloproliferative Disorders
Disorders of Hemostasis Primary hemostasis - formation of a platelet
plug (collagen fibrils and von Willebrand’sfactor (vWF) in the subendothelial matrix of the blood vessel gets exposed to blood)
Secondary hemostasis - vascular damage exposes tissue damage
DISORDERS OF HEMOSTASIS
A. von Willebrandʼs Disease Most common inherited bleeding disorder - Disorder of primary hemostasis - mucosal
and skin bleeding and prolonged oozing aftertrauma or surgery
Rx - replacement of vWF
Disorders of hemostasis
B. Hemophilia Deficiency of clotting factors Disorder of secondary hemostasis - easy
bruising, prolonged bleeding If severe can spontaneously bleed - into
joints, muscles, organs Rx - replacement of clotting factors
Disorders of hemostasis
C. Thrombocytopenia Decreased platelets (< 150,000/mm^3) -
caused by either reduced production orincreased destruction; usually a sign of other problems
Mucosal bleeding is a common sign May be presenting sign of aplastic anemia
(bone marrow failure) Rx - underlying cause; platelet transfusions
Disorders of hemostasis
D. Aspirin / NSAIDs Single dose of ASA can impair platelet
function for 48 hours NSAIDs are less potent ASA and NSAIDs are contraindicated before
surgery
Disorders of hemostasis
E. Disseminated Intravascular Coagulation DIC - thrombotic disease caused by overactivation of
the coagulation cascade - Paradoxical in that clotting and hemorrhage occur
simultaneously within the vascularsystem
Widespread clotting and fibrin deposition in circulation, causes backflow and increased pressure which leads to hemorrhage
Common after shock, sepsis, obsteteric / gynecological complications, cancer, massive trauma
Alteration in normal balance of pro and anticoagulant factors
Rx - underlying cause
Disorders of hemostasis
F. Hemoglobinopathies Abnormalities in the formation of HgB 1. Sickle cell disease (SCD) - Genetic, result is HgB that changes from
biconcave to crescent (sickle) shapeonce oxygen is released - provides selective immunity to malaria but leads todifficulty in blood flow in microvascular resulting in acute and chronic tissue injury
Disorders of hemostasis
Acute crises or episodes - pain caused by blockages of sickled RBCs in anyorgan, bone or joint; location and severity vary widely
Life threatening crises occur when these occur in chest (heart or lung) or CNS
Bone marrow transplant cures SCD Sickle Cell trait - makes both types of HgB -
rarely symptomatic
Disorders of hemostasis
2. Thalassemias - inherited disorder with abnormalities in one of more of the 4 globingenes; leads to varying degrees of abnormally functioning HgB
Clinical manifestations based on extent to which the globin genes are impacted and are related to:
1. defective synthesis of HgB 2. structurally impaired RBCs 3. hemolysis or destruction of RBCs (anemia)
\ impaired oxygen carrying capacity - Rx - transfusions
Disorders of hemostasis
and Sean M. Collins PT, ScD
Created by:Andrea C. Mendes PT, DPT